NASDAQ:BLPH

Bellerophon Therapeutics Short Interest Ratio and Short Volume

$4.16
-0.29 (-6.52 %)
(As of 07/30/2021 12:00 AM ET)
Add
Compare
Today's Range
$4.12
$4.40
50-Day Range
$4.02
$5.48
52-Week Range
$3.79
$12.86
Volume67,807 shs
Average Volume122,499 shs
Market Capitalization$39.54 million
P/E RatioN/A
Dividend YieldN/A
Beta-0.52

Bellerophon Therapeutics (NASDAQ:BLPH) Short Interest Data

Current Short Volume91,200 shares
Previous Short Volume126,800 shares
Change Vs. Previous Month-28.08%
Dollar Volume Sold Short$383,952.00
Short Interest Ratio / Days to Cover0.5
Last Record DateJuly, 15 2021
Outstanding Shares9,506,000 shares
Float Size8,440,000 shares
Short Percent of Float1.08%
Today's Trading Volume67,807 shares
Average Trading Volume122,499 shares
Today's Volume Vs. Average-44.65%

Short Interest Over Time

Days to Cover Over Time

Percentage of Float Shorted Over Time

cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Bellerophon Therapeutics ?

Sign up to receive the latest short interest report for Bellerophon Therapeutics and its competitors with MarketBeat's FREE newsletter.

Bellerophon Therapeutics (NASDAQ:BLPH) Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
7/15/202191,200 shares $383,952.00 -28.1%1.1%0.5 $4.21
6/30/2021126,800 shares $613,712.00 -31.8%1.5%0.7 $4.84
6/15/2021186,000 shares $855,600.00 +13.6%2.2%1.3 $4.60
5/28/2021163,700 shares $677,718.00 +4.7%2.0%2.5 $4.14
5/14/2021156,300 shares $598,629.00 +1.6%1.9%2.3 $3.83
4/30/2021153,800 shares $667,492.00 -54.8%1.9%1.9 $4.34
4/15/2021340,300 shares $1.51 million +2.8%4.2%4 $4.44
3/31/2021331,100 shares $1.72 million +7.6%4.1%4.1 $5.18
3/15/2021307,800 shares $2.11 million +3.1%4.0%3.7 $6.85
2/26/2021298,700 shares $1.98 million +15.4%3.9%3.9 $6.63
2/12/2021258,800 shares $2.06 million +1.7%3.4%3 $7.95
1/29/2021254,600 shares $1.77 million +0.8%3.0%3.3 $6.94
1/15/2021252,500 shares $1.86 million +0.6%2.9%3.5 $7.36
12/31/2020251,100 shares $1.78 million +4.7%2.9%3.8 $7.09
12/15/2020239,800 shares $1.65 million +2.4%2.8%4 $6.90
11/30/2020234,200 shares $1.57 million +45.7%2.7%4.4 $6.72
11/15/2020160,800 shares $1.29 million -1.2%1.9%3 $8.00
10/30/2020162,800 shares $1.34 million -12.1%1.9%3.5 $8.26
10/15/2020185,100 shares $1.71 million -9.8%2.2%3.3 $9.26
9/30/2020205,300 shares $2.09 million -17.0%2.4%2.7 $10.18
9/15/2020247,400 shares $2.63 million -23.6%2.9%2.2 $10.62
8/31/2020324,000 shares $3.50 million -16.8%3.8%2.4 $10.79
8/14/2020389,500 shares $4.62 million +3.7%4.5%2.3 $11.85
7/31/2020375,600 shares $4.82 million -3.6%4.5%1.5 $12.84
7/15/2020389,800 shares $5.29 million -18.2%7.2%1.4 $13.57

Bellerophon Therapeutics (NASDAQ:BLPH) Short Interest FAQ

speech bubbles
speech bubbles











What is Bellerophon Therapeutics' current short interest?

Short interest is the volume of Bellerophon Therapeutics shares that have been sold short but have not yet been closed out or covered. As of July 15th, investors have sold 91,200 shares of BLPH short. 1.08% of Bellerophon Therapeutics' shares are currently sold short. Learn More on Bellerophon Therapeutics' current short interest.

What is a good short interest percentage for Bellerophon Therapeutics?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.08% of Bellerophon Therapeutics' floating shares are currently sold short.

Is Bellerophon Therapeutics' short interest increasing or decreasing?

Bellerophon Therapeutics saw a decline in short interest during the month of July. As of July 15th, there was short interest totaling 91,200 shares, a decline of 28.1% from the previous total of 126,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Bellerophon Therapeutics' float size?

Bellerophon Therapeutics currently has issued a total of 9,506,000 shares. Some of Bellerophon Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Bellerophon Therapeutics currently has a public float of 8,440,000 shares.

How does Bellerophon Therapeutics' short interest compare to its competitors?

1.08% of Bellerophon Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Bellerophon Therapeutics: vTv Therapeutics Inc. (8.74%), BioLineRx Ltd. (0.00%), Larimar Therapeutics, Inc. (2.34%), Novan, Inc. (8.28%), scPharmaceuticals Inc. (1.26%), Calithera Biosciences, Inc. (3.11%), ObsEva SA (1.20%), Oasmia Pharmaceutical AB (publ) (0.00%), Iterum Therapeutics plc (2.09%), and Matinas BioPharma Holdings, Inc. (7.68%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Advanced Micro Devices, Inc. ($7.55 billion), Square, Inc. ($7.47 billion), S&P Global Inc. ($7.40 billion), Analog Devices, Inc. ($6.82 billion), Aon plc ($5.98 billion), Charter Communications, Inc. ($5.10 billion), Wayfair Inc. ($4.38 billion), AMC Entertainment Holdings, Inc. ($2.87 billion), Teladoc Health, Inc. ($2.55 billion), and Nuance Communications, Inc. ($2.41 billion). View all of the most shorted stocks.

What does it mean to sell short Bellerophon Therapeutics stock?

Short selling BLPH is an investing strategy that aims to generate trading profit from Bellerophon Therapeutics as its price is falling. Bellerophon Therapeutics' stock is trading down $0.29 today. To short Bellerophon Therapeutics stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that Bellerophon Therapeutics will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Bellerophon Therapeutics?

A short squeeze for Bellerophon Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of BLPH, which in turn drives the price of the stock up even further.

How often is Bellerophon Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BLPH, twice per month. The most recent reporting period available is July, 15 2021.



This page was last updated on 8/2/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.